skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
p53-HDM2 Interaction Inhibitor MI-773 (Code C106120)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: p53-HDM2 Interaction Inhibitor MI-773

Definition: An orally available spiro-oxindole HDM2 (human double minute 2) antagonist with potential antineoplastic activity. Upon oral administration, the p53-HDM2 protein-protein interaction inhibitor MI-773 binds to HDM2, preventing the binding of the HDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this HDM2-p53 interaction, the proteosome-mediated enzymatic degradation of p53 is inhibited and the transcriptional activity of p53 is restored, which may result in the restoration of p53 signaling and lead to the p53-mediated induction of tumor cell apoptosis. HDM2, a zinc finger protein and a negative regulator of the p53 pathway, is often overexpressed in cancer cells. It has been implicated in cancer cell proliferation and survival.

Display Name: p53-HDM2 Interaction Inhibitor MI-773

Label: p53-HDM2 Interaction Inhibitor MI-773

NCI Thesaurus Code: C106120 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C3853940  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
p53-HDM2 Interaction Inhibitor MI-773
p53-MDM2 Interaction Inhibitor MI-773

External Source Codes: 
PDQ Closed Trial Search ID 737146
PDQ Open Trial Search ID 737146 (check for NCI PDQ open clinical trial info)
UMLS CUI C3853940

Other Properties:
     Name Value (qualifiers indented underneath)
code C106120
Contributing_Source CTRP
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom